Michael J. Currens

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull et al. · PubMed · 1988 · 2.4K citations

Chemoprevention Strategy, Pathology, Cell Culture +22

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

Michael R. Boyd, Kirk R. Gustafson, James B. McMahon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 607 citations · Full text

Viral Replication, Immunology, Escherichia Coli +17

HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

Yoel Kashman, Kirk R. Gustafson, Ray W. Fuller et al. · Journal of Medicinal Chemistry · 1992 · 546 citations

Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms

James B. McMahon, Michael J. Currens, Robert J. Gulakowski et al. · Antimicrobial Agents and Chemotherapy · 1995 · 125 citations

Distinct Mechanisms, Biochemistry, Hiv Life Cycle +15

Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase

Paul L. Boyer, Michael J. Currens, James B. McMahon et al. · Journal of Virology · 1993 · 124 citations · Full text

Immunology, Molecular Biology, Antiviral Drug +21